Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
20
-
Total 13F shares, excl. options
-
2.1M
-
Shares change
-
+176K
-
Total reported value, excl. options
-
$2.18M
-
Value change
-
+$269K
-
Put/Call ratio
-
1.12
-
Number of buys
-
11
-
Number of sells
-
-9
-
Price
-
$1.04
Significant Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q3 2020
30 filings reported holding IGC - IGC Pharma, Inc. - COM NEW as of Q3 2020.
IGC Pharma, Inc. - COM NEW (IGC) has 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.1M shares
.
Largest 10 shareholders include Carroll Financial Associates, Inc. (515K shares), VANGUARD GROUP INC (470K shares), GEODE CAPITAL MANAGEMENT, LLC (262K shares), BRIDGEWAY CAPITAL MANAGEMENT INC (192K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (144K shares), RENAISSANCE TECHNOLOGIES LLC (111K shares), DEARBORN PARTNERS LLC (96.9K shares), NORTHERN TRUST CORP (84.5K shares), GOLDMAN SACHS GROUP INC (66.3K shares), and TRUIST FINANCIAL CORP (36.7K shares).
This table shows the top 20 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.